Published in J Neurol Sci on March 12, 2011
Mobility, balance and falls in persons with multiple sclerosis. PLoS One (2011) 1.28
Falls in people with MS--an individual data meta-analysis from studies from Australia, Sweden, United Kingdom and the United States. Mult Scler (2014) 1.02
DTI Measurements in Multiple Sclerosis: Evaluation of Brain Damage and Clinical Implications. Mult Scler Int (2013) 0.99
The clinical relevance of force platform measures in multiple sclerosis: a review. Mult Scler Int (2013) 0.93
The impact of dynamic balance measures on walking performance in multiple sclerosis. Neurorehabil Neural Repair (2014) 0.88
Fall Incidence as the Primary Outcome in Multiple Sclerosis Falls-Prevention Trials: Recommendation from the International MS Falls Prevention Research Network. Int J MS Care (2014) 0.85
Association of Postural Sway with Disability Status and Cerebellar Dysfunction in People with Multiple Sclerosis: A Preliminary Study. Int J MS Care (2015) 0.80
Interleukin-1β and interleukin-1 receptor antagonist appear in grey matter additionally to white matter lesions during experimental multiple sclerosis. PLoS One (2013) 0.79
The role of clinical and instrumented outcome measures in balance control of individuals with multiple sclerosis. Mult Scler Int (2013) 0.77
Functional connectivity underlying postural motor adaptation in people with multiple sclerosis. Neuroimage Clin (2015) 0.76
Movement strategies for maintaining standing balance during arm tracking in people with multiple sclerosis. J Neurophysiol (2014) 0.75
Characteristics of multiple sclerosis patient stance control disorders, measured by means of posturography and related to brainstem lesions. Audiol Res (2012) 0.75
Quantification of postural stability in minimally disabled multiple sclerosis patients by means of dynamic posturography: an observational study. J Neuroeng Rehabil (2017) 0.75
Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS. Neurology (2013) 4.60
Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring. Lancet Neurol (2011) 2.19
Diffusion-weighted imaging tractography-based parcellation of the human lateral premotor cortex identifies dorsal and ventral subregions with anatomical and functional specializations. J Neurosci (2007) 1.76
Assessing walking disability in multiple sclerosis. Mult Scler (2012) 1.42
Structural and functional bases for individual differences in motor learning. Hum Brain Mapp (2011) 1.27
The diagnostic accuracy of static posturography in predicting accidental falls in people with multiple sclerosis. Neurorehabil Neural Repair (2012) 1.24
Effect of corpus callosum damage on ipsilateral motor activation in patients with multiple sclerosis: a functional and anatomical study. Hum Brain Mapp (2007) 1.21
Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial. BMC Neurol (2014) 1.14
Escalation to natalizumab or switching among immunomodulators in relapsing multiple sclerosis. Mult Scler (2011) 1.14
Home-based balance training using the Wii balance board: a randomized, crossover pilot study in multiple sclerosis. Neurorehabil Neural Repair (2013) 1.14
fMRI evidence of brain reorganization during attention and memory tasks in multiple sclerosis. Neuroimage (2004) 1.11
Safety and tolerability in relapsing-remitting multiple sclerosis patients treated with high-dose subcutaneous interferon-beta by Rebiject autoinjection over a 1-year period: the CoSa study. Clin Neuropharmacol (2008) 1.08
Cortical motor reorganization after a single clinical attack of multiple sclerosis. Brain (2002) 1.05
Assessing the correlation between grey and white matter damage with motor and cognitive impairment in multiple sclerosis patients. PLoS One (2013) 1.04
Computer-aided retraining of memory and attention in people with multiple sclerosis: a randomized, double-blind controlled trial. J Neurol Sci (2004) 1.04
Diffusion-weighted magnetic resonance imaging in patients with partial status epilepticus. Epilepsia (2009) 1.03
Diameter, length, speed, and conduction delay of callosal axons in macaque monkeys and humans: comparing data from histology and magnetic resonance imaging diffusion tractography. J Neurosci (2013) 1.02
Observations during an elective interruption of natalizumab treatment: a post-marketing study. Mult Scler (2010) 1.01
Fate of neutralizing and binding antibodies to IFN beta in MS patients treated with IFN beta for 6 years. J Neurol Sci (2003) 1.01
Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial. J Neurol Sci (2004) 1.01
Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study. Clin Neuropharmacol (2009) 1.00
DTI Measurements in Multiple Sclerosis: Evaluation of Brain Damage and Clinical Implications. Mult Scler Int (2013) 0.99
Predictors of freedom from disease activity in natalizumab treated-patients with multiple sclerosis. J Neurol Sci (2012) 0.98
A longitudinal fMRI study on motor activity in patients with multiple sclerosis. Brain (2005) 0.98
The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis. J Neuroimmunol (2007) 0.96
Clinically isolated syndrome suggestive of multiple sclerosis: voxelwise regional investigation of white and gray matter. Radiology (2009) 0.96
Natalizumab treatment in multiple sclerosis: the experience of S. Andrea MS Centre in Rome. Neurol Sci (2011) 0.95
Multiple sclerosis: white and gray matter damage associated with balance deficit detected at static posturography. Radiology (2013) 0.95
Predictors of long-term clinical response to interferon beta therapy in relapsing multiple sclerosis. J Neurol (2005) 0.95
Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial. Lancet (2004) 0.94
Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study. BMC Neurol (2012) 0.94
Central nervous system involvement in hepatitis C virus cryoglobulinemia vasculitis: a multicenter case-control study using magnetic resonance imaging and neuropsychological tests. J Rheumatol (2005) 0.94
Fingolimod protects cultured cortical neurons against excitotoxic death. Pharmacol Res (2012) 0.94
The clinical relevance of force platform measures in multiple sclerosis: a review. Mult Scler Int (2013) 0.93
Tolosa-Hunt syndrome in a patient with systemic lupus erythematosus. Eur Radiol (2001) 0.92
Multiple sclerosis: altered thalamic resting-state functional connectivity and its effect on cognitive function. Radiology (2014) 0.91
Primary headache and multiple sclerosis: preliminary results of a prospective study. Neurol Sci (2008) 0.91
The impact of interferon beta and natalizumab on comorbid migraine in multiple sclerosis. Headache (2012) 0.91
Contribution of corticospinal tract damage to cortical motor reorganization after a single clinical attack of multiple sclerosis. Neuroimage (2002) 0.90
Gray- and white-matter changes 1 year after first clinical episode of multiple sclerosis: MR imaging. Radiology (2010) 0.90
Isoprostanes in clinically isolated syndrome and early multiple sclerosis as biomarkers of tissue damage and predictors of clinical course. Mult Scler (2012) 0.90
Relating brain damage to brain plasticity in patients with multiple sclerosis. Neurorehabil Neural Repair (2012) 0.89
The relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis: a monthly MRI study after triple-dose gadolinium-DTPA. J Neurol (2004) 0.88
MRI-based analysis of the natalizumab therapeutic window in multiple sclerosis. Mult Scler (2012) 0.88
Neutralizing antibodies explain the poor clinical response to interferon beta in a small proportion of patients with multiple sclerosis: a retrospective study. BMC Neurol (2009) 0.87
A longitudinal study of MR diffusion changes in normal appearing white matter of patients with early multiple sclerosis. Magn Reson Imaging (2002) 0.87
Interferon beta failure predicted by EMA criteria or isolated MRI activity in multiple sclerosis. Mult Scler (2013) 0.87
EEG/fMRI study of ictal and interictal epileptic activity: methodological issues and future perspectives in clinical practice. Epilepsia (2006) 0.87
Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group. Neurol Sci (2013) 0.87
The distribution of magnetic resonance imaging response to interferonbeta-1b in multiple sclerosis. J Neurol (2005) 0.86
Brain reorganization during attention and memory tasks in multiple sclerosis: insights from functional MRI studies. J Neurol Sci (2006) 0.85
Balance deficit with opened or closed eyes reveals involvement of different structures of the central nervous system in multiple sclerosis. Mult Scler (2013) 0.85
Natalizumab treatment in pediatric multiple sclerosis: a case report. Eur J Paediatr Neurol (2008) 0.85
Attachment models affect brain responses in areas related to emotions and empathy in nulliparous women. Hum Brain Mapp (2012) 0.85
Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study. BMC Neurol (2012) 0.84
Long-term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: the Italian experience. Neurol Sci (2009) 0.84
Preservation of motor skill learning in patients with multiple sclerosis. Mult Scler (2010) 0.83
Visuo-proprioceptive training reduces risk of falls in patients with multiple sclerosis. Mult Scler (2010) 0.83
Sex hormones: a role in the control of multiple sclerosis? Expert Opin Pharmacother (2006) 0.83
Drug resistant ADLTE and recurrent partial status epilepticus with dysphasic features in a family with a novel LGI1mutation: electroclinical, genetic, and EEG/fMRI findings. Epilepsia (2009) 0.83
The pharmacovigilance program on natalizumab in Italy: 2 years of experience. Neurol Sci (2009) 0.83
Multiple sclerosis: changes in microarchitecture of white matter tracts after training with a video game balance board. Radiology (2014) 0.81
Impaired cortical deactivation during hand movement in the relapsing phase of multiple sclerosis: a cross-sectional and longitudinal fMRI study. Mult Scler (2011) 0.81
Advances in the treatment of relapsing-remitting multiple sclerosis - critical appraisal of fingolimod. Ther Clin Risk Manag (2013) 0.81
Does giving segmental muscle vibration alter the response to botulinum toxin injections in the treatment of spasticity in people with multiple sclerosis? A single-blind randomized controlled trial. Clin Rehabil (2013) 0.80
Cerebrospinal fluid isoprostanes are not related to inflammatory activity in relapsing-remitting multiple sclerosis. J Neurol Sci (2004) 0.80
The use of ID migraine™ questionnaire in patients with multiple sclerosis. Neurol Sci (2010) 0.80
Evidence of impaired brain activity balance after passive sensorimotor stimulation in multiple sclerosis. PLoS One (2013) 0.79